Jim Cramer Shares His Thoughts On Gilead Sciences, Inc. And Citigroup Inc

On CNBC's Mad Money, Jim Cramer said that Gilead Sciences, Inc. GILD has to do an acquisition. Without it, the stock is not going to move higher, because the company has a lot of cash and not a lot of growth.

Cramer thinks Citigroup Inc C was well prepared for the stress test, and he believes it is a buy at its current price.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: BiotechCNBCLong IdeasJim CramerMediaTrading IdeasGeneralJim CramerMad Money
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!